Concepedia

Werner Embrechts

WE

Statistics

Publications

7

Citations

159

H-Index

7

Active since

2004

Affiliations

Janssen (Belgium)(Current)

Janssen (United States)

Werner Embrechts is an author at Janssen (Belgium) specializing in pharmacology, medicinal chemistry, and pharmacy.

ORCID

Publications per year

2004–2024

7

Publications

7

Novel Pyrimidine Toll-like Receptor 7 and 8 Dual Agonists to Treat Hepatitis B Virus

David C. McGowan, Florence Herschke, Frederik Pauwels et al. · Journal of Medicinal Chemistry · 2016 · 40 citations

, , +17

Design, Synthesis, and Biological Evaluation of Novel Indoles Targeting the Influenza PB2 Cap Binding Region

David C. McGowan, Wendy Balemans, Werner Embrechts et al. · Journal of Medicinal Chemistry · 2019 · 28 citations · Full text

, , +17

2,4-Diaminoquinazolines as Dual Toll-like Receptor (TLR) 7/8 Modulators for the Treatment of Hepatitis B Virus

Werner Embrechts, Florence Herschke, Frederik Pauwels et al. · Journal of Medicinal Chemistry · 2018 · 27 citations · Full text

, , +17

Identification and Optimization of Pyrrolo[3,2-<i>d</i>]pyrimidine Toll-like Receptor 7 (TLR7) Selective Agonists for the Treatment of Hepatitis B

David C. McGowan, Florence Herschke, Frederik Pauwels et al. · Journal of Medicinal Chemistry · 2017 · 20 citations · Full text

, , +17

Synthesis and Biological Evaluation of 1,2,4-Triazinylphenylalkylthiazolecarboxylic Acid Esters as Cytokine-Inhibiting Antedrugs with Strong Bronchodilating Effects in an Animal Model of Asthma

Eddy Freyne, Jean Lacrampe, Frederik Deroose et al. · Journal of Medicinal Chemistry · 2004 · 19 citations

, , +17

1–5 of 7